In 2023, forecasted data indicate Iceland leads with a 2.7% market share, showing a year-on-year increase of 1.55%. Germany follows at 2.3%, despite a -3.16% decline. Ireland (-2.52%), Luxembourg (-5.59%), and Italy (-2.76%) also show negative trends. Notably, South Korea’s sales grew by 4.56%, contrasting with New Zealand’s significant -7.31% decrease. CAGR over the past five years demonstrate these variations are part of broader market trends.
Future trends to watch include market recovery in Germany and Luxembourg, potential continuing growth in South Korea, and possible retraction in New Zealand. Monitoring these dynamics will be crucial for strategic positioning in the Global Systemic Hormonal Preparations market.
Top countries in Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins) by Country
| # | 10 Countries | Percent of Total Sales | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Iceland | 2.7 | 2023 | +3.85% | +1.55% | View data |
| 2 | 2 Germany | 2.3 | 2023 | 0% | -3.16% | View data |
| 3 | 3 Ireland | 2.2 | 2023 | 0% | -2.52% | View data |
| 4 | 4 Luxembourg | 2.1 | 2023 | -4.55% | -5.59% | View data |
| 5 | 5 Czech Republic | 2 | 2023 | 0% | -0.97% | View data |
| 6 | 6 Italy | 2 | 2023 | 0% | -2.76% | View data |
| 7 | 7 Spain | 1.9 | 2023 | 0% | -1.98% | View data |
| 8 | 8 Canada | 1.8 | 2023 | +5.88% | 0% | View data |
| 9 | 9 Denmark | 1.8 | 2023 | 0% | -3.04% | View data |
| 10 | 10 Austria | 1.7 | 2023 | -5.56% | -1.14% | View data |
